Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02742740 · ClinicalTrials.gov registry record · NA
Study Buddy (an ECA Oncology Trial Advisor) for Cancer Trials
A NA study, sponsored by Boston Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT02742740: Completed NA study, sponsored by Boston Medical Center.
NCT02742740 is a NA study that has completed, run by Boston Medical Center. The registered enrollment target is 4 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02742740, a NA study, has completed, sponsored by Boston Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The Study Buddy ECA acts as an advisor to patients on chemotherapy regimens, promoting protocol adherence and retention, providing anticipatory guidance and answering questions, serving as a conduit to capture information about complaints or adverse events, providing a venue for communicating about updates. The Study Buddy will use the web-based ECA infrastructure developed for use on another project. We will use web browsers on tablets provided to study participants to access the Study Buddy, providing anywhere, anytime access to its functions. Usability metrics will include session time, satisfaction, and error rates.
Primary Outcome
How well does the subject adhere to treatment protocol. This will be defined by the number of treatment visits attended/ number of treatment visits scheduled \[excluding any treatment visits that have been cancelled by the clinicians\].
Interventions
- BEHAVIORAL Chemo Buddy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2017-09-01 |
| Est. Completion | 2018-04-30 |
| Phase | NA |
What the finished NCT02742740 record still lists
NCT02742740 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 4 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Chemo Buddy is the first listed.
NCT02742740 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02742740 about?
NCT02742740 is a clinical study titled "Study Buddy (an ECA Oncology Trial Advisor) for Cancer Trials". The Study Buddy ECA acts as an advisor to patients on chemotherapy regimens, promoting protocol adherence and retention, providing anticipatory guidance and answering questions, serving as a conduit to capture information about complaints or adverse events, providing a venue for communicating about ...
What is the current status of trial NCT02742740?
This trial is currently completed. It is a NA study. The enrollment target is 4 participants. The study started on 2017-09-01. Estimated completion is 2018-04-30.
What interventions are being tested in trial NCT02742740?
The interventions under investigation include: Chemo Buddy (BEHAVIORAL).
Who is sponsoring clinical trial NCT02742740?
This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02742740's enrollment target sits among peer trials
4 1996th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI